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Abstract
Background: External, rectilinear biphasic cardioversion (RBC), as against monophasic
cardioversion, requires lower energy and has been documented to be more effective in restoring
sinus rhythm in atrial fibrillation (AF). There is, however, limited data on the optimal protocol
of low energy RBC in atrial flutter (AFl) and regular atrial tachyarrhythmias (AT).
Methods and results: A prospective, single-center study was conducted, wherein 50 con-
secutive patients (mean age: 70.8 ± 8.7; 24 males) undergoing cardioversion of persistent or
paroxysmal AFl or AT were randomized into two protocols of subsequent RBC shocks: 1) 10 J,
20 J, 50 J, 100 J, 200 J or 2) 20 J, 50 J, 100 J, 200 J. Initial energy was effective in 9/28 (32%)
patients using Protocol 1 and in 12/22 (52%) patients using Protocol 2 (NS). In 9/12 patients
with pacemakers, energy of 10 J or 20 J restored sinus or atrial-paced rhythm. Mean cumula-
tive energy and number of shocks was 67 ± 70 J vs 64 ± 62 J (NS) and 2.0 ± 0.8 vs 1.6 ± 0.7
(p = 0.05) for both protocols, respectively. Mean successful energy was higher for AFl patients
than for AT patients 66 ± 49 J vs 30 ± 19 J, p < 0.04. In approximately 25% of patients,
conversion of AFl/AT into AF was observed after initial energy.
Conclusions: Low energy RBC is effective in 32–52% of patients with AFl/AT. Energy of 50 J
is effective in 73% of patients and should be recommended as an initial energy in regular AT.
Low energy RBC may be especially indicated in patients with pacemakers. (Cardiol J 2011; 18,
1: 33–38)
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Introduction
Regular atrial tachyarrhythmias — atrial flut-
ter (AFl) and atrial tachycardia (AT) — are common
disorders that occur in the general population with
a frequency of approximately 0.00088% [1]. Despite
different etiologies, clinical management of both
arrhythmias includes antiarrhythmic drugs, cardio-
version or ablation treatment [2–4].
Current ACC/AHA/ESC guidelines recommend
the use of an external monophasic waveform cardio-
version for termination of atrial arrhythmias with an
initial energy of 50 J and 200 J for AFl and atrial fibril-
lation (AF), respectively [4, 5]. There is no recom-
mendation for cardioversion of atrial tachycardia.
Compared to monophasic cardioversion, external,
rectilinear biphasic cardioversion (RBC) requires less
energy and has been documented to be more effec-
tive in terminating AF [6–8]. The use of low energy
RBC seems to be especially important in patients with
AFl or AT and with an implanted pacemaker due to
possible post-shock sensing or pacing dysfunction.
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There is, however, limited information on the
prospective evaluation of the initial energy settings
of rectilinear RBC required to terminate regular
atrial tachyarrhythmias. Therefore, the aim of this
study was to assess the efficacy and outcome of low
energy RBC protocols in patients with AFl or AT.
Methods
Data collection
A prospective, single-center, randomized study
was conducted. Consecutive patients with AFl or
AT hospitalized between 1 October, 2002 and 25
February, 2007 and classified for DC cardioversion
entered the study. AFl was defined as presence of
F waves, negative in leads II and III, positive in lead
aVR for typical AFl and reversed for atypical AFl
(duration 200–350/min). AT was diagnosed when
atrial rhythm with isoelectric line between every
P wave was present. All patients included in the study
signed an informed consent before the cardiover-
sion procedure.
The research was conducted according to the
guidelines set out in the Declaration of Helsinki and
has been approved by our Institutional Committee
on Human Research.
The exclusion criteria were standard contrain-
dications to cardioversion, such as: duration of ar-
rhythmia lasting longer than 48 hours with no do-
cumented anticoagulation therapy four weeks pri-
or to the procedure or clots in the atria found on
transesophageal echocardiography (TEE). Select-
ed patients were randomized to two protocols (Pro-
tocol 1 or 2) of subsequent rectilinear RBC (ZOLL
M-Series defibrillator, USA) shocks: 1) 10 J, 20 J,
50 J, 100 J, 200 J; or 2) 20 J, 50 J, 100 J, 200 J. Exter-
nal, hand-held paddle electrodes were used in the
sternum-apex position. Patients were sedated rou-
tinely with etomidate. A shock was defined as suc-
cessful if sinus or atrial-paced rhythm was restored
for more than one minute. In cases of induction of
AF after initial RBC shock, patients were treated
with 50 J shock and higher energy setting. The ef-
ficacy of the procedure was assessed during the
24 hours following cardioversion.
Prior to the cardioversion, all patients were
treated with appropriate anticoagulation therapy,
recommended by current guidelines [9]. Patients
with persistent regular atrial tachyarrhythmia
(> 48 h) were treated for four weeks with effective
dosage of vitamin K antagonists (INR range 2.0–
–3.0). In patients with indication for antiarrhythmic
therapy before four weeks of effective anticoagula-
tion, the TEE was performed before cardioversion.
In patients with paroxysmal arrhythmia (<48 h) low
molecular weight heparin was used.
Statistical analysis
Continuous variables are presented as mean ±
± standard deviation (SD) and median values, ca-
tegorical variables were described as frequencies
and percentages. Continuous variables were com-
pared by the unpaired Student t test, and categorical
variables were compared by the c2 test. Statistical
significance was considered when p value < 0.05.
Results
Fifty patients (mean age: 70.8 ± 8.7; 24 males)
were included in the study. Patients’ clinical charac-
teristics are summarized in Tables 1 and 2. No signifi-
cant differences were found between patients assigned
to both protocols. Duration of AFl or AT varied between
one and 360 days (median 12 days) and had no in-
fluence on the result of the procedure. In three pa-
tients, the duration of arrhythmia was unknown.
In the studied group, 91 RBC shocks were de-
livered. Initial energy was efficient in 9/28 (32%)
patients in Protocol 1 (10 J) and in 12/22 (52%)
patients in Protocol 2 (20 J); p = NS. The cumula-
tive success rate for the second stage of Protocol 1
(20 J) was 65%. The restoration of sinus or atrial-
-paced rhythm after a 50 J shock was similar in both
protocols (75% vs 73%, p = NS). The cumulative
success rates for both protocols are shown in
Figure 1.
Mean cumulative energy for restoration of si-
nus or atrial-paced rhythm was 67 ± 70 J (median
60 J) for Protocol 1 and 64 ± 62 J (median 25 J) for
Protocol 2 (p = NS), whereas mean successful en-
ergy was 51 ± 47 J (median 50 J) and 49 ± 39 J (me-
dian 25 J), respectively (p = NS). The mean num-
ber of shocks needed for restoration of sinus or atri-
al paced rhythm was significantly lower for Protocol
2 than for Protocol 1 (1.6 ± 0.7 vs 2.0 ± 0.8; p = 0.05).
Mean cumulative energy, as well as mean suc-
cessful energy required for restoration of sinus or
atrial-paced rhythm, were significantly higher for
AFl patients than for AT patients in both protocols:
93 ± 81 J (median 70 J) vs 38 ± 27 J (median 20 J),
p < 0.04 and 66 ± 49 J (median 50 J) vs 30 ± 19 J
(median 20 J), p < 0.04. Compared to patients with
AT, patients with AFl tended to require a higher
mean number of shocks for restoration of sinus or
atrial-paced rhythm (1.7 ± 0.8 vs 2.0 ± 0.9; p = NS).
The initial energy (10 J or 20 J depending on proto-
cols) was effective in 41% of individuals with AFl
and in 41% of AT patients (p = NS).
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Table 1. Clinical characteristics of patients randomized to Protocol 1 and Protocol 2.
Protocol 1 (n = 28) Protocol 2 ( n= 22) P
Age (years) 72 ± 6 68 ± 5 NS
Male 13 11 NS
AFl/AT 10/18 12/10
Mean AFl/AT duration 111 ± 229 131 ± 234 NS
Weight [kg] 76 ± 8 86 ± 7 NS
Previous TIA 3 1 NS
IHD 12 8 NS
Previous MI 5 6 NS
Previous PTCA 1 1 NS
Previous CABG 1 1 NS
Dyslipidemia 6 8 NS
Active smoking 3 2 NS
Hypertension 21 15 NS
Diabetes 7 7 NS
Previous cardioversion 9 5 NS
History of AF 12 10 NS
History of AFl or AT 8 10 NS
Beta-blocker 19 10 NS
Amiodarone 4 5 NS
Sotalol 4 3 NS
Propafenone 3 3 NS
Continuous variables are expressed as mean ± standard deviation; other values are number of patients; AF — atrial fibrillation; AFl — atrial flutter;
AT — atrial tachyarrhythmia; TIA — transient ischemic attack; IHD — ischemic heart disease; MI — myocardial infarction; PTCA — percutaneous
transluminal coronary angioplasty; CABG — coronary artery bypass grafting
Table 2. Clinical characteristics of patients with atrial flutter and atrial tachyarrhytmia.
AFl (n = 22) AT (n= 28) P
Age (years) 66 ± 9 75 ± 7 < 0.001
Male 13 11 NS
Mean AFl/AT duration 60 ± 85 187 ± 314 NS
Weight [kg] 96 ± 26 74 ± 15 0.02
Previous TIA 0 4 NS
IHD 10 12 NS
Previous MI 6 6 NS
Previous PTCA 0 2 NS
Previous CABG 1 2 NS
Dyslipidemia 8 7 NS
Active smoking 2 3 NS
Hypertension 18 20 NS
Diabetes 7 8 NS
Previous cardioversion 6 12 NS
History of AF 9 14 NS
History of AFl or AT 9 8 NS
Beta-blocker 13 17 NS
Amiodarone 4 7 NS
Sotalol 2 5 NS
Propafenone 3 3 NS
Continuous variables are expressed as mean ± standard deviation; other values are number of patients. AF — atrial fibrillation; AFl — atrial flutter;
AT — atrial tachyarrhythmia; TIA — transient ischemic attack; IHD — ischemic heart disease; MI — myocardial infarction; PTCA — percutaneous
transluminal coronary angioplasty; CABG — coronary artery bypass grafting
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There were 12 patients with permanent atrial
pacing included in the study (DDD pacing: nine
patients; AAI pacing: three patients). Ten individu-
als from that group presented with AT and two with
AFl. In nine of the 12 patients with a pacemaker,
energy of 10 J or 20 J restored a sinus or atrial paced
rhythm. Energy of 10 J was successful in one patient
with AFl and in three patients with AT, whereas 20
J was effective in one patient with AFl and four pa-
tients with AT. In 50% of patients, initial energy was
successful. Mean cumulative energy was 24 ± 15 J
(median 30 J) in that group of patients.
In seven (25%) patients included in Protocol 1
and in four (22%) patients treated according to Pro-
tocol 2, conversions into AF within the first minute
after the initial energy shock were observed. One
patient in Protocol 1 converted into AF after the
second stage of the protocol (20 J). There were no
patients with a pacemaker in that group. There were
no significant differences between these patients
and individuals who did or did not develop AF dur-
ing the procedure. Conversion into AF after initial
energy was observed in 17% of patients with AFl
and in 40% of patients with AT (p = NS). Mean cu-
mulative and mean successful energy for restoration
of sinus rhythm in patients with conversion of AFL/
/AT into AF were significantly higher than in patients
without AF induction: 139 ± 83 J (median 120 J) vs
42 ± 36 (median 25 J); p < 0.001 and 102 ± 43 J
(median 100 J) vs 33 ± 25 J (median 20 J), p < 0.001.
Conversion of AT into AFl was observed in one
patient after initial energy of 10 J.
Forty one out of 91 (45%) RBC shocks were
unsuccessful. In eight of these 41 (19%) shocks, fail-
ure of cardioversion was due to early recurrence of
arrhythmia after few sinus or atrial paced beats,
whereas in the remaining 33 (81%) cases, cardio-
version was unsuccessful even for a few seconds.
In the early recurrence group, the same arrhyth-
mia appeared again after 3/8 (36%) unsuccessful
shocks; in the other five cases (64%), AF was in-
duced after shocks.
There were no significant differences in the
pharmacological treatment of both groups. In the
AFl group, three patients was treated with amio-
darone prior to cardioversion, and after the first
stage of the protocol two of them converted into AF.
In another three patients in that group, propafenone
was used before DC shocks and there was no con-
version into AF in that group. The restoration of
sinus or paced atrial rhythm was achieved in all but
one patient (98%). No serious complication (occur-
rence of post-cardioversion bradyarrhythmia,
thromboembolic events, skin burns or pacing and
sensing disorders in patients with implanted pace-
maker) were noted. No early or late recurrent atrial
arrhythmias were observed during 24-hours of
observation.
Discussion
Our study revealed that a protocol of RBC for
cardioversion of AFl/AT with initial energy of 20 J
is slightly, but not significantly, more effective than
a protocol starting with 10 J. Furthermore, the sig-
nificantly lower number of shocks decrease the to-
tal time needed for procedure and duration of anaes-
thesia. These observations, with the similar rate
of conversion into AF, favour the use of 20 J as the
initial energy level.
This result agrees with recent studies that
showed that for monophasic cardioversion of AFl,
starting protocol from higher initial energy (50 J to
80 J) is effective and provides lower cumulative
energy [5]. Other studies have suggested there is no
statistical difference in success rates between 50 J
monophasic and 20 J RBC (69% vs 66%, p = NS);
moreover the RBC energy of 30 J was significantly
more effective than monophasic 100 J [8]. It was also
shown that for AFl, mean overall successful ener-
gy of RBC and monophasic cardioversion is 61 ±
± 46 J and 231 ± 108 J, respectively [7]. Similarly,
there is evidence that the success rate of RBC and
monophasic 20 J shocks was 41% and 42% of pa-
tients (p = NS), respectively, whereas 50 J shocks
Figure 1. The cumulative success rates for every step
of Protocols 1 and 2.
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were effective in 77% and 80% of the patients
(p = NS) [10]. In the same study, median energy
for successful cardioversion was 50 J in both types
of electrical waveforms. Optimal initial RBC ener-
gy seems to be 20 J or 50 J and it needs further pro-
spective evaluation and verification of incidence of
conversion into AF after RBC.
Conversion of AFl or AT into AF after low en-
ergy shocks was observed in earlier studies on
monophasic cardioversion and it appears to be a li-
mitation of low energy RBC [7]. In our recent study
with 302 consecutive patients with persistent AF,
the mean cumulative and mean successful energy
needed for restoring sinus rhythm of RBC were
165 ± 140 J and 98 ± 69 J, respectively [11]. Si-
milar results in patients converted into AF were
obtained in this study.
The prevalence of induction of AF after
monophasic cardioversion, as well as after low en-
ergy RBC, in patients with regular atrial tachy-
arrythmias has not been investigated in other stu-
dies. It seems that inducted AF is more frequent in
low energy cardioversion and should be treated with
a dosage of energy appropriate for a patient cardio-
verted due to AF as a primary disease. The impor-
tance and frequency of conversion into AF in
monophasic and RBC with different initial energies
needs further comparative evaluation.
The high success rate of low energy settings
in patients with a pacemaker may be a result of low-
er weight in that group of patients (68.63 ± 13.12
vs 88.00 ± 23.14, p = 0.01). There were no differ-
ences in age or arrhythmia duration in both groups.
Another potential explanation for high efficacy of
RBC in paced patients is the favorable influence of
pacing, preventing early arrhythmia recurrences.
There have been no previous studies evaluat-
ing external monophasic or biphasic cardioversion
in AT. The results for the AT group were not com-
pared to any other studies, but it seems that for
cardioversion of AT in comparison to AFl, signifi-
cantly lower RBC energy is required.
Limitations of the study
The protocol of the study was focused on the
procedure of cardioversion. The number of patients
included in the study limited investigation on the
influence of duration of symptoms and medications
before and after RBC. Due to 24 hours follow up,
the study shows the short-term effectiveness of the
RBC. The proportion of patients with a pacemaker
was low. Comparison of sternum-apex and antero-
-posterior configuration for cardioversion of AT and
AFl needs further evaluation, however antero-pos-
terior configuration may be less appropriate for
patients with pacemakers because it will mean the
device will be closer. Antero-posterior configura-
tion needs additional patches. We use paddles as
a standard in our institution.
Conclusions
Low energy RBC is effective in 32–52% of pa-
tients, and may be especially indicated in patients
with pacemakers in whom limitation of DC current
is desirable. Low energy RBC is associated with
about 20% of conversion into AF. Patients with AT
and AFL had similar outcome of low energy RBC;
therefore for both arrhythmias, a similar initial en-
ergy and protocol setting can be used. Due to a 74%
cumulative success rate of energy of 50 J, mean
successful energy about 50 J in both protocols, and
risk of conversion into AF associated with lower
initial RBC energies, energy of 50 J is the minimal
acceptable energy needed to restore sinus or atri-
al-paced rhythm in AFl/AT. Energy of 50 J should
be recommended for the RBC of regular atrial ta-
chyarrhythmias and needs to be compared as an
initial energy with higher settings.
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